ADAR1 Capital Management, LLC
24 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | INM | InMed Pharmaceuticals Inc. | Buy | 1,000 | $1.56 | $1,555.00 | filing |
| 2026-05-19 | INM | InMed Pharmaceuticals Inc. | Buy | 200,000 | $1.56 | $312,080.00 | filing |
| 2026-05-19 | INM | InMed Pharmaceuticals Inc. | Buy | 200,000 | $1.50 | $299,800.00 | filing |
| 2026-05-19 | RLYB | Rallybio Corp | Buy | 10,000 | $13.98 | $139,822.00 | filing |
| 2026-05-19 | INM | InMed Pharmaceuticals Inc. | Buy | 68,551 | $1.60 | $109,667.89 | filing |
| 2026-05-19 | RLYB | Rallybio Corp | Buy | 200 | $13.80 | $2,760.00 | filing |
| 2026-05-18 | RLYB | Rallybio Corp | Buy | 6,009 | $13.98 | $83,981.18 | filing |
| 2026-05-15 | RLYB | Rallybio Corp | Buy | 200 | $13.95 | $2,790.00 | filing |
| 2026-05-15 | RLYB | Rallybio Corp | Buy | 100 | $13.80 | $1,380.00 | filing |
| 2026-05-13 | RLYB | Rallybio Corp | Buy | 75,178 | $14.00 | $1.1M | filing |
| 2026-05-13 | RLYB | Rallybio Corp | Buy | 4,081 | $13.80 | $56,314.94 | filing |
| 2026-05-12 | RLYB | Rallybio Corp | Buy | 800 | $13.83 | $11,063.04 | filing |
| 2026-05-11 | RLYB | Rallybio Corp | Buy | 25,000 | $14.00 | $350,000.00 | filing |
| 2026-05-11 | RLYB | Rallybio Corp | Buy | 19,900 | $14.00 | $278,600.00 | filing |
| 2026-05-11 | RLYB | Rallybio Corp | Buy | 5,100 | $14.00 | $71,391.84 | filing |
| 2026-05-05 | RLYB | Rallybio Corp | Buy | 35,101 | $14.00 | $491,259.56 | filing |
| 2026-05-04 | RLYB | Rallybio Corp | Buy | 116,904 | $13.97 | $1.6M | filing |
| 2026-05-04 | RLYB | Rallybio Corp | Buy | 3,900 | $13.90 | $54,201.42 | filing |
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | Sale | 4,391,237 | $17.75 | $77.9M | filing |
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | Sale | 743,358 | $17.75 | $13.2M | filing |
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | Sale | 254,669 | $17.75 | $4.5M | filing |
| 2025-06-20 | KROS | Keros Therapeutics, Inc. | X | 1,400 | $70.00 | $98,000.00 | filing |
| 2025-06-20 | KROS | Keros Therapeutics, Inc. | X | 200 | $70.00 | $14,000.00 | filing |
| 2025-06-20 | KROS | Keros Therapeutics, Inc. | X | 100 | $60.00 | $6,000.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.